Treatment | Page 378 of 465

Aging :: DHEA not an anti-aging compound for elderly adults

Taking supplements of the hormone dehydroepiandrosterone, better known as DHEA, does not improve body composition, physical performance, insulin sensitivity, or quality of life in elderly adults, according to a report in The New England Journal of Medicine. The new findings strongly contradict advertisements promoting these supplements as anti-aging compounds, lead author Dr. K. Sreekumaran Nair, from the Mayo Clinic in Rochester, Minnesota, and colleagues conclude.

Diabetes :: Benefits of Actos – pioglitazone for type 2 diabetes unclear

According to a review of clinical trials, benefits of pioglitazone for type 2 diabetes is unclear. Marketed by Takeda Pharmaceuticals and Eli Lilly & Co. as Actos, pioglitazone belongs to a class of drugs called thiazolidinediones that work by increasing the body’s sensitivity to insulin, to better control patients’ blood sugar. It is used alone or in combination with other drugs if diabetes can’t be controlled by diet and exercise.

Renal Failure :: Homeopathy in Chronic Renal or Kidney failure (CRF)

Chronic Renal (Kidney) Failure is a fatal disease where bodily waste products (in the form of urine) collected in the body which leads to multiorgan failure. There are three procedures in modern medicine for such condition –

Osteoporosis :: Reduce risk of osteoporosis – Dairy Council of California

Osteoporosis, a disease characterized by low bone mass that often leads to fractures of the hip, spine and wrist, affects more than 5 million Californians, most of whom are women.(1) In observation of World Osteoporosis Day on October 20, Dairy Council of California offers tips to help women and their families reduce their risk of osteoporosis throughout their lifetimes by eating a healthy diet rich in calcium and other bone-building nutrients, and participating in weight-bearing cardiovascular activities.

Schizophrenia :: AstraZeneca’s SEROQUEL SR for Schizophrenia in EU and Canada

AstraZeneca today announced further submissions to Regulatory Authorities for the approval of the sustained release (SR) once-daily formulation of SEROQUEL? for the treatment of patients with schizophrenia, including Canada and a Marketing Authorisation Application (MAA) in the European Union (EU) under Mutual Recognition Procedure (MRP). The submission will cover all markets in the EU where SEROQUEL? is currently approved.

Eyes :: Donning protective glasses clearly key to eye-injury prevention

Accidental eye injury is a leading cause of visual impairment nationally, yet nearly 70 percent of those injured weren’t wearing protective eyewear, the main preventive measure, say ophthalmologists at UT Southwestern Medical Center, say ophthalmologists at UT Southwestern Medical Center.

Breast Cancer :: Breast-cancer revelation not solely limited to detecting lumps

Women should be aware that not every type of breast cancer reveals itself with a lump during self exams. An aggressive, fast-spreading form called inflammatory breast cancer (IBC) grows in nests or sheets of cancer cells that spread through the breast. Because it is relatively rare, IBC is often diagnosed late or even misdiagnosed as an infection.

Breast Cancer :: Mammograms reduce breast cancer deaths, but increase overdiagnosis

A new review of studies offers good news and bad news for women faced with the decision about whether to get regular mammograms. The good news is that screening mammography does reduce breast cancer mortality. The review found that women offered screening mammograms are 15 percent less likely to die of breast cancer than women who are not offered mammograms.

Cancer :: Cancer stem cells linked to radiation resistance

Certain types of brain cancer cells, called cancer stem cells, help brain tumors to buffer themselves against radiation treatment by activating a “repair switch” that enables them to continue to grow unchecked, researchers at Duke University Medical Center have found.

Asthma :: New asthma medicine – Xolair – targeting vulnerable inner-city children

UT Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma.